{"nct_id":"NCT03814746","title":"Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-07-26","start_date_type":"ACTUAL","primary_completion_date":"2022-08-31","primary_completion_date_type":"ACTUAL","completion_date":"2026-12-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}